| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTELLUS MEDICAL INC | 3,489,533 | 63,475,000 | 47.43% | ||
| 2 | TRANSENTERIX INC | 7,546,692 | 32,073,000 | 23.96% | ||
| 3 | OCULAR THERAPEUTIX INC | 1,932,607 | 18,669,000 | 13.95% | ||
| 4 | Catabasis Pharmaceuticals Inc | 2,857,667 | 14,403,000 | 10.76% | ||
| 5 | RAPTOR PHARMACEUTICAL CORP | 888,132 | 4,085,000 | 3.05% | ||
| 6 | LOMBARD MEDICAL INC | 1,077,499 | 1,131,000 | 0.85% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017019, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
